NO20012311L - Fremgangsmåte for å forebygge og helbrede aterosklerose hos pattedyr - Google Patents
Fremgangsmåte for å forebygge og helbrede aterosklerose hos pattedyrInfo
- Publication number
- NO20012311L NO20012311L NO20012311A NO20012311A NO20012311L NO 20012311 L NO20012311 L NO 20012311L NO 20012311 A NO20012311 A NO 20012311A NO 20012311 A NO20012311 A NO 20012311A NO 20012311 L NO20012311 L NO 20012311L
- Authority
- NO
- Norway
- Prior art keywords
- aliquot
- preventing
- mammal
- mammals
- procedure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
En fremgangsmåte for å forebygge progresjon og å forårsake tilbakegang av aterosklerose hos et pattedyr som omfatter: (a) å behandle en aliquot av blod fra pattedyr ex-vivo med minst en stressfaktor valgt fra gruppen bestående av en temperatur over eller under kroppstemperatur, et elektromagnetisk utslipp og et oksydativt miljø; og (b) å administrere aliquoten av blod som er behandlet i trinn (a) til pattedyret, der aliquoten har et volum som er tilstrekkelig til å oppnå en tilbakegang av en eksisterende ateroskleroselesjon hos pattedyret.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19023698A | 1998-11-13 | 1998-11-13 | |
| US09/304,262 US6264646B1 (en) | 1998-11-13 | 1999-05-06 | Method for preventing and reversing atherosclerosis in mammals |
| PCT/CA1999/001092 WO2000029003A2 (en) | 1998-11-13 | 1999-11-15 | Method for preventing and reversing atherosclerosis in mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012311D0 NO20012311D0 (no) | 2001-05-10 |
| NO20012311L true NO20012311L (no) | 2001-07-02 |
Family
ID=26885899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012311A NO20012311L (no) | 1998-11-13 | 2001-05-10 | Fremgangsmåte for å forebygge og helbrede aterosklerose hos pattedyr |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1128837B1 (no) |
| JP (1) | JP2002529510A (no) |
| CN (1) | CN1230182C (no) |
| AT (1) | ATE233093T1 (no) |
| AU (1) | AU768300B2 (no) |
| BR (1) | BR9915270A (no) |
| CA (1) | CA2348599A1 (no) |
| CZ (1) | CZ20011642A3 (no) |
| DE (1) | DE69905602T2 (no) |
| DK (1) | DK1128837T3 (no) |
| EA (1) | EA003421B1 (no) |
| ES (1) | ES2192885T3 (no) |
| MX (1) | MXPA01004801A (no) |
| NO (1) | NO20012311L (no) |
| NZ (1) | NZ511467A (no) |
| WO (1) | WO2000029003A2 (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2271190A1 (en) | 1999-05-06 | 2000-11-06 | Vasogen Ireland Limited | Improved method for treating mammals with modified mammalian blood |
| EP1218017B1 (en) | 1999-09-24 | 2005-11-16 | Vasogen Ireland Limited | Combination of a statin and ex-vivo treated blood for treating atherosclerosis |
| CA2309417A1 (en) | 2000-05-25 | 2001-11-25 | Anthony E. Bolton | Apoptotic entities for use in treatment of endothelium dysfunction disorders |
| WO2005097145A1 (en) * | 2004-04-12 | 2005-10-20 | Vasogen Ireland Limited | Myocarditis treatment |
| WO2008000067A1 (en) * | 2006-06-26 | 2008-01-03 | Vasogen Ireland Limited | Treatment of mild chronic heart failure in human patients |
| RU2475275C1 (ru) * | 2011-08-08 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения облитерирующего атеросклероза артерий нижних конечностей |
| RU2475274C1 (ru) * | 2011-08-09 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения атеросклероза артерий нижних конечностей |
| RU2475276C1 (ru) * | 2011-08-09 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения облитерирующего атеросклероза артерий нижних конечностей |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD249143A3 (de) * | 1985-03-20 | 1987-09-02 | Ilmenau Tech Hochschule | Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes |
| US5980954A (en) * | 1992-02-07 | 1999-11-09 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
| WO1993015778A1 (en) * | 1992-02-07 | 1993-08-19 | Anthony Ernest Bolton | Method of inhibiting the aggregation of blood platelets |
-
1999
- 1999-11-15 EA EA200100543A patent/EA003421B1/ru not_active IP Right Cessation
- 1999-11-15 MX MXPA01004801A patent/MXPA01004801A/es not_active IP Right Cessation
- 1999-11-15 NZ NZ511467A patent/NZ511467A/xx not_active IP Right Cessation
- 1999-11-15 JP JP2000582049A patent/JP2002529510A/ja not_active Withdrawn
- 1999-11-15 AT AT99972104T patent/ATE233093T1/de not_active IP Right Cessation
- 1999-11-15 BR BR9915270-3A patent/BR9915270A/pt not_active Application Discontinuation
- 1999-11-15 CN CNB998146390A patent/CN1230182C/zh not_active Expired - Fee Related
- 1999-11-15 DE DE69905602T patent/DE69905602T2/de not_active Expired - Lifetime
- 1999-11-15 EP EP99972104A patent/EP1128837B1/en not_active Expired - Lifetime
- 1999-11-15 CA CA002348599A patent/CA2348599A1/en not_active Abandoned
- 1999-11-15 WO PCT/CA1999/001092 patent/WO2000029003A2/en active IP Right Grant
- 1999-11-15 ES ES99972104T patent/ES2192885T3/es not_active Expired - Lifetime
- 1999-11-15 AU AU11450/00A patent/AU768300B2/en not_active Ceased
- 1999-11-15 DK DK99972104T patent/DK1128837T3/da active
- 1999-11-15 CZ CZ20011642A patent/CZ20011642A3/cs unknown
-
2001
- 2001-05-10 NO NO20012311A patent/NO20012311L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU768300B2 (en) | 2003-12-04 |
| CA2348599A1 (en) | 2000-05-25 |
| JP2002529510A (ja) | 2002-09-10 |
| NO20012311D0 (no) | 2001-05-10 |
| ATE233093T1 (de) | 2003-03-15 |
| DE69905602D1 (de) | 2003-04-03 |
| CN1330549A (zh) | 2002-01-09 |
| MXPA01004801A (es) | 2002-09-18 |
| DK1128837T3 (da) | 2003-06-16 |
| CZ20011642A3 (cs) | 2002-06-12 |
| WO2000029003A2 (en) | 2000-05-25 |
| EP1128837A2 (en) | 2001-09-05 |
| EA003421B1 (ru) | 2003-04-24 |
| CN1230182C (zh) | 2005-12-07 |
| BR9915270A (pt) | 2003-12-30 |
| ES2192885T3 (es) | 2003-10-16 |
| WO2000029003A3 (en) | 2000-08-31 |
| AU1145000A (en) | 2000-06-05 |
| EP1128837B1 (en) | 2003-02-26 |
| DE69905602T2 (de) | 2003-10-09 |
| EA200100543A1 (ru) | 2001-10-22 |
| NZ511467A (en) | 2002-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69923671D1 (de) | Verwendung von kannabidiol als entzündunghemmende mittel | |
| EA199800667A1 (ru) | Новые фенантридины | |
| CA2400801A1 (en) | Treatment of congestive heart failure by pretreated autologous blood | |
| MY135766A (en) | Quinolinones and naphthyridinones for treating inflammatory diseases | |
| EA200100571A1 (ru) | Комбинированный способ лечебного воздействия, включающий применение лучевой терапии и ингибитора циклооксигеназы-2(cox-2) для лечения неоплазии | |
| NO20012311D0 (no) | Fremgangsmåte for å forebygge og helbrede aterosklerose hos pattedyr | |
| DE59908408D1 (de) | Holzbehandlungsverfahren | |
| ATE211921T1 (de) | Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata | |
| AU4779599A (en) | Methods of inhibiting (helicobacter pylori) | |
| NO20016380L (no) | Fremgangsmåte for å forhindre tumorvekst | |
| PT968715E (pt) | Loratadina para utilizacao como agente anti-arritmico | |
| NZ515727A (en) | Aminotetralin derivative for the therapy of cardiovascular diseases | |
| ID28174A (id) | Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya | |
| DE69030181D1 (de) | Verwendung von cromakalim/brl 38227 zur behandlung der überreaktivität der luftwege | |
| EA199800058A1 (ru) | Способ лечения доброкачественной гиперплазии предстательной железы, лекарственная форма для лечения доброкачественной гиперплазии, содержащая агонист мелатонина | |
| UA22165A (uk) | Спосіб гастродуодеhопластики | |
| UA30521A (uk) | Спосіб лікування доброякісної гіперплазії передміхурової залози у поєднанні з хронічним калькульозним простатитом | |
| ES2144851T3 (es) | Procedimiento para el tratamiento biologico-termico de residuos. | |
| UA15164A (uk) | Спосіб детоксикації при захворюваhhях оргаhів гепатопаhкреатобіліарhої зоhи запальhого геhезу | |
| UA30987A (uk) | Спосіб лікування уретритів | |
| UA40096A (uk) | Спосіб лікування шизофренії | |
| UA32288A (uk) | Спосіб лікування дегенеративних і запальних процесів |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |